Vaginal Estradiol Cost in North Dakota (2026): Prices, Insurance, and Savings

What Does Vaginal Estradiol Actually Cost in North Dakota?

The average cash price for brand-name vaginal estradiol across North Dakota retail pharmacies is approximately $120 per month in 2026, based on reported dispensing data. The manufacturer list price reaches $280 per month, but few patients pay that amount out of pocket. Your actual cost depends on whether you use insurance, a savings card, or a compounding pharmacy. A 2016 Cochrane systematic review confirmed that low-dose vaginal estradiol is effective and well-tolerated for GSM symptoms, supporting its continued clinical use across all formulations 1.

Three formulations dominate the North Dakota market: vaginal cream (Estrace), the vaginal ring (Estring), and vaginal tablets (Vagifem/Yuvafem). Cream tends to be the least expensive at retail, while the ring commands a higher upfront cost but lasts 90 days per insertion. The FDA-approved labeling for these products specifies the lowest effective dose for the shortest duration consistent with treatment goals 2. Generic vaginal estradiol tablets (estradiol 10 mcg) have driven prices down since their initial approval, and North Dakota pharmacies stock generics widely.

Pricing varies by as much as $40 between pharmacies in Fargo and those in smaller communities like Williston or Dickinson. Calling ahead or using a price-comparison tool before filling your prescription is worth the effort.

North Dakota Medicaid Does Not Cover Vaginal Estradiol for GSM

North Dakota Medicaid currently excludes vaginal estradiol prescribed for genitourinary syndrome of menopause from its formulary. This gap affects a significant number of postmenopausal women in the state. The 2022 Endocrine Society clinical practice guideline recommends vaginal estrogen as first-line therapy for moderate to severe GSM symptoms 3, yet coverage has not followed. Patients enrolled in North Dakota Medicaid who need vaginal estradiol have limited options but not zero options.

Prior authorization requests can sometimes succeed if a prescriber documents failure of non-hormonal alternatives such as ospemifene or vaginal moisturizers. The success rate is low. For patients denied coverage, compounded vaginal estradiol through a 503A pharmacy offers the most affordable alternative, and manufacturer copay cards may reduce costs if the patient has a qualifying commercial plan through a spouse or employer.

The North American Menopause Society (NAMS) 2022 position statement notes that "the decision to use hormone therapy should be individualized based on a woman's symptoms, health history, and personal preferences" 4. North Dakota's Medicaid exclusion means that individualization is, for some women, constrained by cost rather than clinical judgment.

Compounded Vaginal Estradiol Is Legal and Available Through 503A Pharmacies

Compounded vaginal estradiol is legal in North Dakota when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits these pharmacies to compound medications that are not essentially copies of commercially available products, and state-level regulation in North Dakota allows 503A operations 5. Cost through 503A compounding can be substantially lower than branded retail products.

Compounded formulations often use estriol-estradiol (Biest) blends or estradiol-only bases in customized concentrations. The trade-off: compounded products do not carry FDA approval, and batch-to-batch variability can occur. The American College of Obstetricians and Gynecologists (ACOG) advises that FDA-approved vaginal estradiol products should be used preferentially when available, reserving compounded formulations for patients with documented allergies to inactive ingredients or cost barriers that prevent access to approved products 6.

A practical note: not every North Dakota community has a local compounding pharmacy. Patients in rural areas like the western Bakken region may need to use mail-order compounding services. Several 503A pharmacies licensed in neighboring states (Minnesota, Montana) ship to North Dakota addresses legally.

Insurance Coverage Beyond Medicaid: What Commercial Plans Pay

Commercial insurance plans in North Dakota vary widely in their coverage of vaginal estradiol. Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica all include at least one vaginal estradiol formulation on their formularies, though tier placement and copay amounts differ. Generic vaginal estradiol tablets typically sit on Tier 2 (preferred brand) or Tier 1 (generic) depending on the plan, with copays ranging from $10 to $45 per month.

Brand-name Estrace cream and the Estring vaginal ring are more commonly placed on Tier 3 (non-preferred brand), requiring copays of $50 to $75 or coinsurance of 25% to 40%. Step therapy requirements may apply. Some plans require patients to try vaginal tablets before approving cream or ring formulations. Medicare Part D plans generally cover vaginal estradiol, though formulary placement and out-of-pocket costs vary by plan. The 2023 AACE/ACE menopause guideline recommends low-dose vaginal estrogen as first-line GSM treatment regardless of formulation 7, which can support appeals when a preferred formulation causes side effects.

Dr. JoAnn Pinkerton, former executive director of NAMS, has stated: "Vaginal estrogen at low doses has minimal systemic absorption and should be accessible to all women with GSM symptoms, including breast cancer survivors on aromatase inhibitors" 8. Coverage decisions should reflect this safety profile.

Manufacturer Savings Cards and North Dakota Discount Programs

Manufacturer savings cards can reduce out-of-pocket costs to as little as $25 per month for commercially insured patients. The Estrace savings program, Vagifem/Yuvafem copay card, and Estring patient assistance programs each operate slightly differently. Patients without any insurance may qualify for zero-cost supplies through manufacturer patient assistance programs (PAPs), though income verification and enrollment paperwork are required.

Here is how savings cards typically work in North Dakota. You present the card at the pharmacy alongside your insurance. The card covers the difference between your copay and the promotional price, up to a maximum annual benefit (often $1,200 to $1,800 per year). Government insurance recipients (Medicaid, Medicare, Tricare, VA) are not eligible for these cards per federal anti-kickback statute requirements.

GoodRx and RxSaver coupons also apply at most North Dakota pharmacies and can bring the cash price of generic vaginal estradiol tablets to $60 to $85 per month at Walmart, Walgreens, and independent pharmacies. Costco Pharmacy in Fargo consistently reports some of the lowest cash prices in the state, and a Costco membership is not required to use the pharmacy.

North Dakota does not operate a state-specific pharmaceutical assistance program for menopausal hormone therapy. The closest equivalent is the North Dakota Department of Human Services' medication assistance referral line, which directs callers to manufacturer PAPs and community health centers that may carry samples.

Telehealth Access to Vaginal Estradiol in North Dakota

North Dakota permits telehealth prescribing of vaginal estradiol statewide. A provider licensed in North Dakota can evaluate symptoms, review medical history, and write a prescription during a video or phone visit. This matters especially for women in rural western North Dakota, where the nearest gynecologist or menopause specialist may be 100 miles or more away.

The prescribing workflow is straightforward. During a telehealth visit, the provider assesses GSM symptoms (vaginal dryness, dyspareunia, urinary urgency), confirms no contraindications, and selects the appropriate formulation and dose. For most patients, vaginal estradiol 10 mcg tablets twice weekly or 0.5 g of 0.01% cream twice weekly serves as the standard maintenance regimen 2. No in-person pelvic exam is required before initiating low-dose vaginal estrogen, per ACOG and NAMS guidance 9.

HealthRX offers telehealth visits with providers licensed in North Dakota who can prescribe vaginal estradiol and coordinate with your preferred pharmacy or a 503A compounding pharmacy for fulfillment. The entire process, from consultation to prescription delivery, typically takes 3 to 5 business days.

Comparing Vaginal Estradiol Formulations by Cost and Convenience

Not all vaginal estradiol products cost the same, and the cheapest option is not always the best fit. Here is how the three main formulations compare for North Dakota patients.

Vaginal estradiol tablets (Vagifem, Yuvafem, or generic estradiol 10 mcg) cost $80 to $120 per month at retail, are the easiest to use (no applicator mess), and have the most generic competition. A 2019 randomized trial (N=302) in Obstetrics & Gynecology found vaginal tablets and cream equally effective for reducing GSM symptoms at 12 weeks 10.

Vaginal estradiol cream (Estrace 0.01%) runs $100 to $150 per month. Dosing flexibility is an advantage since your provider can titrate the amount applied. Some patients dislike the messiness of cream application.

The vaginal estradiol ring (Estring) costs $250 to $350 per unit but lasts 90 days, making the monthly equivalent $85 to $115. The ring requires no twice-weekly dosing, which improves adherence. A study in Menopause (2014, N=159) showed the ring produced sustained symptom relief with less dosing burden 11.

For patients paying out of pocket in North Dakota, generic vaginal tablets or the ring (calculated monthly) tend to be the most cost-effective choices. Cream occupies a middle ground: more expensive than tablets for most patients, but useful when a specific dose needs to be adjusted up or down.

Safety Profile and Monitoring at Low Doses

Low-dose vaginal estradiol produces minimal systemic absorption. Serum estradiol levels remain within the normal postmenopausal range (<20 pg/mL) with the 10 mcg tablet and the 2 mg ring 12. This finding matters for women with a history of breast cancer or thromboembolic disease, populations where systemic estrogen is contraindicated.

The 2020 ACOG Committee Opinion confirmed that low-dose vaginal estrogen does not require concomitant progestogen therapy, even in women with an intact uterus, because endometrial stimulation at these doses is negligible 9. Routine endometrial monitoring with transvaginal ultrasound is not indicated for patients on low-dose vaginal estradiol unless abnormal bleeding develops.

No special laboratory monitoring is required. Patients should report any unexpected vaginal bleeding to their prescriber, and an annual clinical assessment of symptom control is standard practice. For breast cancer survivors considering vaginal estradiol, a shared decision-making conversation with the oncology team is recommended. The DATA study (Menopause, 2021, N=1,843) found no increase in breast cancer recurrence among aromatase inhibitor users who also used low-dose vaginal estrogen 13.

How to Get the Lowest Price in North Dakota

Start with your insurance formulary. If vaginal estradiol tablets are on Tier 1 or 2, your copay may already be $10 to $30 per month, making savings cards unnecessary. Check your plan's formulary online or call the number on the back of your card.

If you are uninsured or your plan does not cover vaginal estradiol, compare these options in order of typical savings: (1) manufacturer patient assistance program (free for qualifying incomes), (2) compounded vaginal estradiol from a 503A pharmacy, (3) GoodRx or RxSaver coupon at a high-volume pharmacy like Costco Fargo or Walmart, (4) manufacturer savings card if you have any commercial coverage.

Ask your prescriber whether a 90-day supply is clinically appropriate. Most North Dakota pharmacies and mail-order services offer a per-unit discount on 90-day fills, reducing monthly cost by 10% to 20%. The vaginal ring already comes as a 90-day product, so this tip applies mainly to tablets and cream.

For patients in Grand Forks, Bismarck, Minot, or smaller communities, independent pharmacies sometimes match or beat chain prices when asked directly. Price transparency in pharmacy is improving but remains inconsistent, so asking is the single most effective cost-reduction strategy available to you right now.